Summary: Recently, the US Federal Drug Administration (FDA) approved a new medication for seizures and epilepsy, Rufinamide. Rufinamide will soon be available for us in the US. In this episode of Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews Dr. Greg Krauss an international renowned epilepsy specialist from Johns Hopkins University. This show will be taped live but no questions will be answered live on the air.
